KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Encompass Health (EHC) Shares Repurchased (2016 - 2026)

Encompass Health (EHC) has disclosed Shares Repurchased for 10 consecutive years, with $71.6 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Repurchased rose 123.05% year-over-year to $71.6 million; the TTM value through Mar 2026 reached $197.5 million, up 212.5%, while the annual FY2025 figure was $158.0 million, 408.04% up from the prior year.
  • Shares Repurchased hit $71.6 million in Q1 2026 for Encompass Health, down from $76.3 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $76.3 million in Q4 2025 and bottomed at $6.8 million in Q3 2024.
  • Average Shares Repurchased over 3 years is $32.6 million, with a median of $24.8 million recorded in 2025.
  • On a YoY basis, Shares Repurchased climbed as much as 917.33% in 2025 and fell as far as 47.02% in 2025.
  • Encompass Health's Shares Repurchased stood at $7.5 million in 2024, then soared by 917.33% to $76.3 million in 2025, then decreased by 6.16% to $71.6 million in 2026.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $71.6 million, $76.3 million, and $24.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.